Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Diabetes

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 129 articles:
HTML format



Single Articles


    July 2020
  1. KAMRATH C, Monkemoller K, Biester T, Rohrer TR, et al
    Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany.
    JAMA. 2020 Jul 20. pii: 2768716. doi: 10.1001/jama.2020.13445.
    PubMed    


  2. HAMPTON T
    Insulin Given With DPP4 Inhibitors Might Protect Blood Vessels in Patients With Diabetes.
    JAMA. 2020;324:15-16.
    PubMed    


  3. CALLAGHAN BC, Price RS, Feldman EL
    Distal Symmetric Polyneuropathy in 2020.
    JAMA. 2020;324:90-91.
    PubMed    


  4. HORNE BD, Grajower MM, Anderson JL
    Limited Evidence for the Health Effects and Safety of Intermittent Fasting Among Patients With Type 2 Diabetes.
    JAMA. 2020 Jul 2. pii: 2768095. doi: 10.1001/jama.2020.3908.
    PubMed    


    June 2020
  5. LAFFEL LM, Kanapka LG, Beck RW, Bergamo K, et al
    Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2020;323:2388-2396.
    PubMed     Abstract available


  6. PRATLEY RE, Kanapka LG, Rickels MR, Ahmann A, et al
    Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2020;323:2397-2406.
    PubMed     Abstract available


  7. AGARWAL S, Cappola AR
    Continuous Glucose Monitoring in Adolescent, Young Adult, and Older Patients With Type 1 Diabetes.
    JAMA. 2020;323:2384-2385.
    PubMed    


  8. KURTH T, Rist PM, Ridker PM, Kotler G, et al
    Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women.
    JAMA. 2020;323:2281-2289.
    PubMed     Abstract available


    May 2020
  9. KOFF A, Malinis M
    Chest Pain and a Cavitary Lung Mass in a Woman With Diabetes.
    JAMA. 2020 May 22. pii: 2766596. doi: 10.1001/jama.2020.4111.
    PubMed    


  10. HIRSCH IB, Gaudiani LM
    Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.
    JAMA. 2020 May 22. pii: 2766597. doi: 10.1001/jama.2020.1303.
    PubMed    


    April 2020
  11. DE BOER IH, Zelnick LR, Manson JE
    Kidney Function in Patients With Type 2 Diabetes After Vitamin D Supplementation-Reply.
    JAMA. 2020;323:1411-1412.
    PubMed    


  12. PEIRIS AN
    Kidney Function in Patients With Type 2 Diabetes After Vitamin D Supplementation.
    JAMA. 2020;323:1411.
    PubMed    


    March 2020
  13. PETRIE MC, Verma S, Docherty KF, Inzucchi SE, et al
    Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
    JAMA. 2020 Mar 27. pii: 2763950. doi: 10.1001/jama.2020.1906.
    PubMed     Abstract available


  14. RAY KK, Nicholls SJ, Buhr KA, Ginsberg HN, et al
    Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2020 Mar 27. pii: 2763951. doi: 10.1001/jama.2020.3308.
    PubMed     Abstract available


    January 2020
  15. KUEHN B
    Prediabetes in Youth.
    JAMA. 2020;323:302.
    PubMed    


  16. LI Z, Heber D
    Ketogenic Diets.
    JAMA. 2020;323:386.
    PubMed    


  17. ZIEGLER AG, Kick K, Bonifacio E, Haupt F, et al
    Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany.
    JAMA. 2020;323:339-351.
    PubMed     Abstract available


  18. SLOMSKI A
    Dapagliflozin Cut Risk of Worsening Heart Failure.
    JAMA. 2020;323:301.
    PubMed    


    December 2019
  19. CHENG YJ, Kanaya AM, Araneta MRG, Saydah SH, et al
    Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016.
    JAMA. 2019;322:2389-2398.
    PubMed     Abstract available


  20. MATSUSHITA K, Tang O, Selvin E
    Addressing Challenges and Implications of National Surveillance for Racial/Ethnic Disparities in Diabetes.
    JAMA. 2019;322:2387-2388.
    PubMed    


    November 2019
  21. DE BOER IH, Zelnick LR, Ruzinski J, Friedenberg G, et al
    Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2019 Nov 8. pii: 2755300. doi: 10.1001/jama.2019.17380.
    PubMed     Abstract available


  22. VOELKER R
    Study Identifies Primary Care Knowledge Gaps and Barriers in Type 2 Diabetes Prevention.
    JAMA. 2019 Nov 6. pii: 2755345. doi: 10.1001/jama.2019.18024.
    PubMed    


    October 2019
  23. SLOMSKI A
    Diabetes, Prior PCI, and Dual Antiplatelet Therapy.
    JAMA. 2019;322:1544.
    PubMed    


  24. WILLIAMS J, Loeffler M
    Global Trends in Type 2 Diabetes, 2007-2017.
    JAMA. 2019;322:1542.
    PubMed    


  25. GREGG EW, Hora I, Benoit S
    Reasons for Increases in Complications of Diabetes-Reply.
    JAMA. 2019;322:1519.
    PubMed    


  26. BUSE JB
    Reasons for Increases in Complications of Diabetes.
    JAMA. 2019;322:1518-1519.
    PubMed    


  27. NOTLEY SR, Poirier MP, Sigal RJ, D'Souza A, et al
    Exercise Heat Stress in Patients With and Without Type 2 Diabetes.
    JAMA. 2019;322:1409-1411.
    PubMed    


  28. FLORY J, Lipska K
    Metformin for Type 2 Diabetes-Reply.
    JAMA. 2019;322:1313.
    PubMed    


  29. PATEL JJ, Mundi MS
    Metformin for Type 2 Diabetes.
    JAMA. 2019;322:1312-1313.
    PubMed    


  30. CATURANO A, Galiero R, Pafundi PC
    Metformin for Type 2 Diabetes.
    JAMA. 2019;322:1312.
    PubMed    


  31. CHEN TK, Knicely DH, Grams ME
    Chronic Kidney Disease Diagnosis and Management: A Review.
    JAMA. 2019;322:1294-1304.
    PubMed     Abstract available


    September 2019
  32. MCCOY RG, Rodriguez-Gutierrez R
    Measuring the Quality of Diabetes Care-Reply.
    JAMA. 2019;322:1212-1213.
    PubMed    


  33. GIUGLIANO D, Maiorino MI, Esposito K
    Measuring the Quality of Diabetes Care.
    JAMA. 2019;322:1212.
    PubMed    


  34. ROUMIE CL, Chipman J, Min JY, Hackstadt AJ, et al
    Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function.
    JAMA. 2019 Sep 19:1-11. doi: 10.1001/jama.2019.13206.
    PubMed     Abstract available


  35. ROSENSTOCK J, Kahn SE, Johansen OE, Zinman B, et al
    Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
    JAMA. 2019 Sep 19. pii: 2751398. doi: 10.1001/jama.2019.13772.
    PubMed     Abstract available


  36. AMINIAN A, Zajichek A, Arterburn DE, Wolski KE, et al
    Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity.
    JAMA. 2019 Sep 2. pii: 2749478. doi: 10.1001/jama.2019.14231.
    PubMed     Abstract available


  37. LIVINGSTON EH
    The Role of Bariatric Surgery in Managing the Macrovascular Complications of Obesity-Related Type 2 Diabetes.
    JAMA. 2019 Sep 2. pii: 2749475. doi: 10.1001/jama.2019.14577.
    PubMed    


    August 2019
  38. SLOMSKI A
    Vitamin D Doesn't Protect Against Diabetes.
    JAMA. 2019;322:717.
    PubMed    


  39. SHAH NS, Lloyd-Jones DM, O'Flaherty M, Capewell S, et al
    Trends in Cardiometabolic Mortality in the United States, 1999-2017.
    JAMA. 2019;322:780-782.
    PubMed    


  40. ABBASI J
    Type 1 Diabetes Advances Could Pave Way for Prevention.
    JAMA. 2019 Aug 21. pii: 2748913. doi: 10.1001/jama.2019.10432.
    PubMed    


  41. ANDREN ARONSSON C, Lee HS, Hard Af Segerstad EM, Uusitalo U, et al
    Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk.
    JAMA. 2019;322:514-523.
    PubMed     Abstract available


    July 2019
  42. KUEHN B
    Diabetes Incidence Decreases.
    JAMA. 2019;322:108.
    PubMed    


  43. SIMHA V, Shah P
    Glucose Control in the Perioperative Period-Reply.
    JAMA. 2019;322:82-83.
    PubMed    


  44. FINUCANE TE
    Glucose Control in the Perioperative Period.
    JAMA. 2019;322:82.
    PubMed    


    May 2019
  45. FLORY J, Lipska K
    Metformin in 2019.
    JAMA. 2019;321:1926-1927.
    PubMed    


  46. ALEXOPOULOS AS, Blair R, Peters AL
    Management of Preexisting Diabetes in Pregnancy: A Review.
    JAMA. 2019;321:1811-1819.
    PubMed     Abstract available



  47. Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes.
    JAMA. 2019;321:1720-1721.
    PubMed    


  48. VOERMAN E, Santos S, Inskip H, Amiano P, et al
    Association of Gestational Weight Gain With Adverse Maternal and Infant Outcomes.
    JAMA. 2019;321:1702-1715.
    PubMed     Abstract available


    April 2019
  49. CHEW EY
    Patients With Good Vision and Diabetic Macular Edema Involving the Center of the Macula: To Treat or Not to Treat?
    JAMA. 2019 Apr 29. pii: 2732607. doi: 10.1001/jama.2019.5793.
    PubMed    


  50. BAKER CW, Glassman AR, Beaulieu WT, Antoszyk AN, et al
    Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
    JAMA. 2019 Apr 29. pii: 2732608. doi: 10.1001/jama.2019.5790.
    PubMed     Abstract available


  51. LUM E, Jimenez G, Huang Z, Thai L, et al
    Decision Support and Alerts of Apps for Self-management of Blood Glucose for Type 2 Diabetes.
    JAMA. 2019;321:1530-1532.
    PubMed    


  52. HIRSCH IB
    The Future of the GLP-1 Receptor Agonists.
    JAMA. 2019;321:1457-1458.
    PubMed    


  53. RUBIN R
    Dr Schrier Goes to Congress as Second Woman Physician.
    JAMA. 2019;321:1443-1445.
    PubMed    


  54. GREGG EW, Hora I, Benoit SR
    Resurgence in Diabetes-Related Complications.
    JAMA. 2019 Apr 15. pii: 2730953. doi: 10.1001/jama.2019.3471.
    PubMed    


  55. RODRIGUEZ-GUTIERREZ R, McCoy RG
    Measuring What Matters in Diabetes.
    JAMA. 2019 Apr 15. pii: 2730954. doi: 10.1001/jama.2019.4310.
    PubMed    


    March 2019
  56. ROSENSTOCK J, Allison D, Birkenfeld AL, Blicher TM, et al
    Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.
    JAMA. 2019 Mar 23. pii: 2729339. doi: 10.1001/jama.2019.2942.
    PubMed     Abstract available


  57. ABBASI J
    Quick Uptakes: After Rotavirus Vaccine, Australia's Type 1 Diabetes Incidence Declines.
    JAMA. 2019 Mar 13. pii: 2728577. doi: 10.1001/jama.2019.0766.
    PubMed    


  58. GLASSMAN AR
    Errors in Analysis of Mean Deviations in Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy.
    JAMA. 2019;321:1007-1008.
    PubMed    



  59. Errors in Analysis of Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy.
    JAMA. 2019;321:1008.
    PubMed    


  60. BALDUCCI S, D'Errico V, Haxhi J, Sacchetti M, et al
    Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes: The IDES_2 Randomized Clinical Trial.
    JAMA. 2019;321:880-890.
    PubMed     Abstract available


    February 2019
  61. LOWE WL JR, Scholtens DM, Metzger BE
    Gestational Diabetes and Childhood Obesity-Reply.
    JAMA. 2019;321:708-709.
    PubMed    


  62. BRADSHAW JM, Ensor SJA, Lorenz HAL
    Gestational Diabetes and Childhood Obesity.
    JAMA. 2019;321:708.
    PubMed    


  63. SKIPPER N, Gaulke A, Sildorf SM, Eriksen TM, et al
    Association of Type 1 Diabetes With Standardized Test Scores of Danish Schoolchildren.
    JAMA. 2019;321:484-492.
    PubMed     Abstract available


    January 2019
  64. LUO J, Khan NF, Manetti T, Rose J, et al
    Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
    JAMA. 2019;321:374-384.
    PubMed     Abstract available


  65. LIPSKA KJ
    Insulin Analogues for Type 2 Diabetes.
    JAMA. 2019;321:350-351.
    PubMed    


  66. ZHENG SL, Roddick AJ
    Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.
    JAMA. 2019;321:277-287.
    PubMed     Abstract available


  67. NAGPAL SJS, Chari ST
    Immunoglobulin G4 Levels.
    JAMA. 2019;321:202-203.
    PubMed    


  68. SIMHA V, Shah P
    Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery.
    JAMA. 2019 Jan 7. pii: 2720429. doi: 10.1001/jama.2018.20922.
    PubMed    


  69. GRENNAN D
    Diabetic Foot Ulcers.
    JAMA. 2019;321:114.
    PubMed    


    December 2018
  70. LOTTA LA, Wittemans LBL, Zuber V, Stewart ID, et al
    Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
    JAMA. 2018;320:2553-2563.
    PubMed     Abstract available


  71. SLOMSKI A
    Dual Receptor Agonist for Type 2 Diabetes.
    JAMA. 2018;320:2521.
    PubMed    


    November 2018
  72. TUNG EL, Davis AM, Laiteerapong N
    Guidelines on Glycemic Targets for Persons With Type 2 Diabetes-Reply.
    JAMA. 2018;320:1937-1938.
    PubMed    


  73. KANSAGARA D, Qaseem A, Wilt TJ
    Guidelines on Glycemic Targets for Persons With Type 2 Diabetes.
    JAMA. 2018;320:1937.
    PubMed    


  74. ROSENSTOCK J, Perkovic V, Johansen OE, Cooper ME, et al
    Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
    JAMA. 2018 Nov 9. pii: 2714646. doi: 10.1001/jama.2018.18269.
    PubMed     Abstract available


    October 2018
  75. ABBASI J
    To Prevent Cardiovascular Disease, Pay Attention to Pregnancy Complications.
    JAMA. 2018 Oct 17. pii: 2708197. doi: 10.1001/jama.2018.14645.
    PubMed    


  76. FISHER DP, Johnson E, Haneuse S, Arterburn D, et al
    Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
    JAMA. 2018;320:1570-1582.
    PubMed     Abstract available


  77. KING WC, Hinerman AS, Belle SH, Wahed AS, et al
    Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes.
    JAMA. 2018;320:1560-1569.
    PubMed     Abstract available


  78. SENAT MV, Affres H, Bouyer J
    Glyburide vs Insulin for Gestational Diabetes-Reply.
    JAMA. 2018;320:1384.
    PubMed    


  79. PENG S, Li C, Sun X
    Glyburide vs Insulin for Gestational Diabetes.
    JAMA. 2018;320:1383-1384.
    PubMed    


  80. OSPINA NS, Young WF Jr, Ghayee HK
    Diagnostic Testing for Elevated Cortisol in the Setting of an Adrenal Mass.
    JAMA. 2018;320:1373-1374.
    PubMed    


    September 2018
  81. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;320:1163-1171.
    PubMed     Abstract available


  82. LEBLANC ES, Patnode CD, Webber EM, Redmond N, et al
    Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;320:1172-1191.
    PubMed     Abstract available


  83. JIN J
    Behavioral Interventions for Weight Loss.
    JAMA. 2018;320:1210.
    PubMed    


  84. LOWE WL JR, Scholtens DM, Lowe LP, Kuang A, et al
    Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity.
    JAMA. 2018;320:1005-1016.
    PubMed     Abstract available


    August 2018
  85. ABBASI J
    Oral GLP-1 Analog for Type 2 Diabetes on the Horizon.
    JAMA. 2018;320:539.
    PubMed    


    June 2018
  86. RUBIN R
    Phone Apps for Patients With Diabetes.
    JAMA. 2018;319:2469.
    PubMed    


  87. XIANG AH, Wang X, Martinez MP, Page K, et al
    Maternal Type 1 Diabetes and Risk of Autism in Offspring.
    JAMA. 2018 Jun 23. pii: 2685775. doi: 10.1001/jama.2018.7614.
    PubMed    


  88. LIPSKA KJ, Parker MM, Moffet HH, Huang ES, et al
    Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    JAMA. 2018 Jun 23. pii: 2685850. doi: 10.1001/jama.2018.7993.
    PubMed     Abstract available


  89. CROWLEY MJ, Maciejewski ML
    Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward?
    JAMA. 2018 Jun 23. pii: 2685849. doi: 10.1001/jama.2018.8033.
    PubMed    



  90. Ertugliflozin for Type 2 Diabetes.
    JAMA. 2018;319:2434-2435.
    PubMed    


  91. TUNG EL, Davis AM, Laiteerapong N
    Glycemic Control in Nonpregnant Adults With Type 2 Diabetes.
    JAMA. 2018;319:2430-2431.
    PubMed    


    May 2018
  92. ABBASI J
    For Patients With Type 2 Diabetes, What's the Best Target Hemoglobin A1C?
    JAMA. 2018 May 30. pii: 2683543. doi: 10.1001/jama.2018.5420.
    PubMed    


  93. HEWITT DB, Barnard C, Bilimoria KY
    Improving Emergency Insulin Administration-Reply.
    JAMA. 2018;319:1937-1938.
    PubMed    


  94. SENAT MV, Affres H, Letourneau A, Coustols-Valat M, et al
    Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2018;319:1773-1780.
    PubMed     Abstract available


  95. COUSTAN DR, Barbour L
    Insulin vs Glyburide for Gestational Diabetes.
    JAMA. 2018;319:1769-1770.
    PubMed    


    April 2018
  96. ZHENG SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, et al
    Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.
    JAMA. 2018;319:1580-1591.
    PubMed     Abstract available


  97. SHAPIRO AR
    Continuous Glucose Monitors for Insulin Dosing-Reply.
    JAMA. 2018;319:1384.
    PubMed    


  98. BECK RW
    Continuous Glucose Monitors for Insulin Dosing.
    JAMA. 2018;319:1383.
    PubMed    


    March 2018
  99. COGSWELL ME, Loria CM, Terry AL, Zhao L, et al
    Estimated 24-Hour Urinary Sodium and Potassium Excretion in US Adults.
    JAMA. 2018;319:1209-1220.
    PubMed     Abstract available


  100. DE BOER IH, Bakris G, Cannon CP
    Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations.
    JAMA. 2018 Mar 15. pii: 2675563. doi: 10.1001/jama.2018.0642.
    PubMed    


    February 2018
  101. MOORE A, Derry S, Wiffen P
    Gabapentin for Chronic Neuropathic Pain.
    JAMA. 2018;319:818-819.
    PubMed     Abstract available


  102. VOELKER R
    Diabetic Foot Ulcers Heal With Shock Wave Therapy.
    JAMA. 2018;319:649.
    PubMed    


  103. SCHILLINGER D, Huey N
    Messengers of Truth and Health-Young Artists of Color Raise Their Voices to Prevent Diabetes.
    JAMA. 2018 Feb 14. pii: 2672777. doi: 10.1001/jama.2018.0986.
    PubMed    


  104. KARGES B, Binder E, Rosenbauer J
    Complications With Insulin Pump Therapy vs Insulin Injection Therapy-Reply.
    JAMA. 2018;319:503-504.
    PubMed    


    January 2018
  105. IKRAMUDDIN S, Korner J, Lee WJ, Thomas AJ, et al
    Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    JAMA. 2018;319:266-278.
    PubMed     Abstract available


  106. ABBASI J
    Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes.
    JAMA. 2018;319:215-217.
    PubMed    


  107. JAKOBSEN GS, Smastuen MC, Sandbu R, Nordstrand N, et al
    Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities.
    JAMA. 2018;319:291-301.
    PubMed     Abstract available


  108. SALMINEN P, Helmio M, Ovaska J, Juuti A, et al
    Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    JAMA. 2018;319:241-254.
    PubMed     Abstract available


  109. SHUBECK S, Dimick JB, Telem DA
    Long-term Outcomes Following Bariatric Surgery.
    JAMA. 2018;319:302-303.
    PubMed    


  110. KNIP M, Akerblom HK, Al Taji E, Becker D, et al
    Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
    JAMA. 2018;319:38-48.
    PubMed     Abstract available


  111. HAMPTON T
    Smart Artificial Beta Cells May Help Treat Diabetes.
    JAMA. 2018;319:11-12.
    PubMed    


    December 2017
  112. BANCKS MP, Kershaw K, Carson AP, Gordon-Larsen P, et al
    Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood.
    JAMA. 2017;318:2457-2465.
    PubMed     Abstract available


  113. RIED-LARSEN M, Johansen MY, Pedersen BK
    Intensive Lifestyle Intervention for Type 2 Diabetes-Reply.
    JAMA. 2017;318:2494-2495.
    PubMed    


  114. GIUGLIANO D, Maiorino MI, Esposito K
    Intensive Lifestyle Intervention for Type 2 Diabetes.
    JAMA. 2017;318:2494.
    PubMed    


  115. TING DSW, Cheung CY, Lim G, Tan GSW, et al
    Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
    JAMA. 2017;318:2211-2223.
    PubMed     Abstract available


    November 2017
  116. SLOMSKI A
    Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.
    JAMA. 2017;318:1968.
    PubMed    


  117. SLOMSKI A
    Continuous Glucose Monitoring in Pregnant Women With Diabetes.
    JAMA. 2017;318:1968.
    PubMed    


  118. KRISCHER JP, Schatz DA, Bundy B, Skyler JS, et al
    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1891-1902.
    PubMed     Abstract available


  119. LANE W, Bailey TS, Gerety G
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
    JAMA. 2017;318:1828-1829.
    PubMed    


  120. ZULEWSKI H, Keller U
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes.
    JAMA. 2017;318:1828.
    PubMed    


  121. SHAHRAZ S, Pittas AG, Saadati M, Thomas CP, et al
    Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014.
    JAMA. 2017;318:1825-1827.
    PubMed    


    October 2017
  122. SLOMSKI A
    Liraglutide May Reduce Diabetic Kidney Disease.
    JAMA. 2017;318:1532.
    PubMed    


  123. GAO P, Tang X, Hu Y
    Prediabetes Prevalence in China-Reply.
    JAMA. 2017;318:1612-1613.
    PubMed    


  124. FU N, Jiang Y, Sun W
    Prediabetes Prevalence in China.
    JAMA. 2017;318:1611-1612.
    PubMed    


  125. DAVIES M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, et al
    Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1460-1470.
    PubMed     Abstract available


  126. VOS RC, Rutten GEHM
    Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
    JAMA. 2017;318:1489-1490.
    PubMed     Abstract available


  127. KARGES B, Schwandt A, Heidtmann B, Kordonouri O, et al
    Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    JAMA. 2017;318:1358-1366.
    PubMed     Abstract available


  128. HART T, Milner R, Cifu A
    Management of a Diabetic Foot.
    JAMA. 2017;318:1387-1388.
    PubMed    


    August 2017
  129. KUEHN BM
    Pilot Programs Seek to Integrate Genomic Data Into Practice.
    JAMA. 2017;318:410-412.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: